KeraVet Gel Study Shows Preference Over Traditional Collars
Clinical Study Reveals Pet Parents' Preference for KeraVet Gel
KeraVet Bio, Inc. has recently concluded a clinical study demonstrating that pet parents favor using KeraVet Gel over the traditional Elizabethan collar, commonly known as the cone. This clinical study followed a previous research initiative that highlighted the product's effectiveness, showing a notable reduction in licking behavior and improved healing outcomes for pets.
Study Overview and Findings
The clinical study involved 20 patients from a veterinary clinic, all of whom would normally require a cone for post-treatment care. In this study, pet parents were randomly assigned into two groups: one received the cone, while the other utilized KeraVet Gel. The findings were quite striking, with 80% of pet owners in the cone group opting for a change to KeraVet Gel after experiencing the disadvantages of the cone.
Furthermore, an impressive 86% of those who used KeraVet Gel reported positively on their pet's recovery. Participant feedback was overwhelmingly positive, with comments highlighting how the gel effectively prevented pets from licking their wounds, allowing for a quicker healing process. One pet owner remarked, "The gel kept my dog from licking her granuloma which allowed the area to start healing," showcasing the product's utility in real-world scenarios.
Veterinary Perspectives on KeraVet Gel
Veterinary clinicians involved in the study were also highly impressed with KeraVet Gel. They rated it a 4 out of 5 overall and expressed gratitude for having an alternative to the traditional cone. One clinician noted, "It really helped to have a second option for pet owners that didn't want an E-collar," indicating that this product may fill an important need among veterinary practitioners and pet owners alike.
KeraVet Gel's Impact on Pet Aftercare
Dr. Luke Burnett, Founder and CEO of KeraVet Bio, shared his insights, stating that the results from this study align perfectly with feedback the company has received since the product's launch. He affirmed that KeraVet Gel is not just a product but a solution with evidence supporting its efficacy in improving quality of life for both pets and their parents.
This innovative wound care solution by KeraVet Bio offers a scientific alternative for managing post-operative care without the stress often associated with using cones. By allowing pets to recover comfortably without the hindrance of an E-collar, KeraVet Gel stands out as a modern option in veterinary medicine.
About KeraVet Bio, Inc.
KeraVet Bio, Inc. specializes in developing advanced veterinary wound care products, with KeraVet Gel being their flagship offering. The company is headquartered in Winston-Salem, North Carolina, and focuses on utilizing keratin biomaterials to create cutting-edge therapeutic solutions for various veterinary needs. Their commitment to innovation is evident in their ongoing research and product development efforts.
Conclusion
Overall, the completion of this clinical study underscores the increasing recognition of KeraVet Gel as an effective alternative to traditional cones for pet aftercare. With ongoing developments and positive feedback from both pet parents and veterinary professionals, KeraVet Bio, Inc. is poised to continue making significant strides in the veterinary field.
Frequently Asked Questions
What is KeraVet Gel used for?
KeraVet Gel is a veterinary wound care product used to promote healing and prevent licking in pets following surgery or injury.
How does KeraVet Gel compare to traditional cones?
Unlike traditional cones, KeraVet Gel allows for better comfort and mobility for pets, while still effectively managing their wounds.
What were the key findings of the clinical study?
The study demonstrated that a significant majority of pet parents preferred KeraVet Gel to the cone, with 86% reporting positive healing outcomes.
Who conducts the studies for KeraVet Bio products?
KeraVet Bio collaborates with veterinary clinics and professionals to conduct controlled clinical studies on their products.
How can I learn more about KeraVet Bio, Inc.?
Further information about KeraVet Bio and its products can typically be found on their official website or by contacting their customer service.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Recent Articles
- VICI Properties Reports Outstanding Q3 2024 Performance
- Target Hospitality Updates Bylaws for Enhanced Governance and Clarity
- Richtech Robotics Faces Compliance Challenge as Stock Struggles
- Exploring Growth in the Global Persulfates Market
- Granite Point Mortgage Solidifies Financial Strategy with JPMorgan
- Excelerate Energy Boosts Dividend as Growth Initiatives Continue
- Rowley Law PLLC Investigates Altair Engineering Inc. Acquisition
- Equillium’s Downgrade: Navigating Challenges in Biotechnology
- Juniper Networks' Q3 2024 Results: Strong Performance Insights
- U.S. Steel's Profitable Q3 Performance Sparks Investor Interest
- Apple Exceeds Earnings Expectations with Strong Revenue Growth
- Bovespa Sees Downtime Amid Mixed Sector Performance
- U.S. Steel Corporation Announces Significant Dividend Update
- BJ's Restaurants Faces Setback with Q3 Loss Despite Revenue Growth
- Enpro Announces Quarterly Dividend to Shareholders
- Canadian Market Update: S&P/TSX Composite Faces Active Decline
- 1847 Holdings LLC Achieves Milestone with $11.1M Offering
- Market Update: U.S. Stocks Retreat Amidst Sector Losses
- Apple Inc. Announces Record Q4 Results and Product Launches
- CubeSmart Shares Positive Q3 Results and Future Strategies